Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Trials
Published in: Trials 1/2018

Open Access 01-12-2018 | Commentary

Multiple-level stakeholder engagement in malaria clinical trials: addressing the challenges of conducting clinical research in resource-limited settings

Authors: George Mtove, Joshua Kimani, William Kisinza, Geofrey Makenga, Peter Mangesho, Stephan Duparc, Miriam Nakalembe, Kamija S. Phiri, Russell Orrico, Ricardo Rojo, Pol Vandenbroucke

Published in: Trials | Issue 1/2018

Login to get access

Abstract

Background

Multinational clinical trials are logistically complex and require close coordination between various stakeholders. They must comply with global clinical standards and are accountable to multiple regulatory and ethical bodies. In resource-limited settings, it is challenging to understand how to apply global clinical standards to international, national, and local factors in clinical trials, making multiple-level stakeholder engagement an important element in the successful conduct of these clinical trials.

Main body

During the planning and implementation of a large multinational clinical trial for intermittent preventive treatment of malaria in pregnancy in resource-limited areas of sub-Saharan Africa, we encountered numerous challenges, which required implementation of a range of engagement measures to ensure compliance with global clinical and regulatory standards. These challenges included coordination with ongoing global malaria efforts, heterogeneity in national regulatory structures, sub-optimal healthcare infrastructure, local practices and beliefs, and perspectives that view healthcare providers with undue trust or suspicion.
In addition to engagement with international bodies, such as the World Health Organization, the Malaria in Pregnancy Consortium, the Steve Biko Centre for Bioethics, and the London School of Hygiene and Tropical Medicine, in order to address the challenges just described, Pfizer Inc. and Medicines for Malaria Venture (the “Sponsoring Entities” for these studies) and investigators liaised with national- and district-level stakeholders such as health ministers and regional/local community health workers. Community engagement measures undertaken by investigators included local meetings with community leaders to explain the research aims and answer questions and concerns voiced by the community. The investigators also engaged with family members of prospective trial participants in order to be sensitive to local practices and beliefs.

Conclusion

Engagement with key stakeholders at international and national levels enabled the Sponsoring Entities to address challenges by aligning the study design with the requirements of health and regulatory agencies and to understand and address healthcare infrastructure needs prior to trial initiation. Local stakeholder engagement, including community members, study participants, and family enabled the investigators to address challenges by ensuring that study design and conduct were adapted to local considerations and ensuring accurate information about the study aims was shared with the public.

Trial registration

ClinicalTrials.gov, ID: NCT01103063. Registered on 7 April 2010.
Literature
1.
Okello G, Jones C, Bonareri M, Ndegwa SN, McHaro C, Kengo J, et al. Challenges for consent and community engagement in the conduct of cluster randomized trial among school children in low income settings: experiences from Kenya. Trials. 2013;14:142.CrossRefPubMedPubMedCentral
2.
Shapiro HT, Meslin EM. Ethical issues in the design and conduct of clinical trials in developing countries. N Engl J Med. 2001;345:139–42.CrossRefPubMed
3.
Pare Toe L, Ravinetto RM, Dierickx S, Gryseels C, Tinto H, Rouamba N, et al. Could the decision of trial participation precede the informed consent process? Evidence from Burkina Faso. PLoS One. 2013;8:e80800.CrossRefPubMedPubMedCentral
4.
Fisher JA. Expanding the frame of “voluntariness” in informed consent: structural coercion and the power of social and economic context. Kennedy Inst Ethics J. 2013;23:355–79.CrossRefPubMed
5.
6.
Kingori P. The “empty choice”: a sociological examination of choosing medical research participation in resource-limited Sub-Saharan Africa. Curr Sociol. 2015;63:763–78.CrossRefPubMedPubMedCentral
7.
8.
Osamor PE, Grady C. Women’s autonomy in health care decision-making in developing countries: a synthesis of the literature. Int J Womens Health. 2016;8:191–202.CrossRefPubMedPubMedCentral
9.
Kimani J, Phiri K, Kamiza S, Duparc S, Ayoub A, Rojo R, et al. Efficacy and safety of azithromycin-chloroquine versus sulfadoxine-pyrimethamine for intermittent preventive treatment of Plasmodium falciparum malaria infection in pregnant women in Africa: an open-label, randomized trial. PLoS One. 2016;11:e0157045.CrossRefPubMedPubMedCentral
10.
11.
World Health Organization. Updated WHO policy recommendation. Intermittent Preventive Treatment of malaria in pregnancy using Sulfadoxine-Pyrimethamine (IPTp-SP). 2012.
12.
Sagara I, Oduro AR, Mulenga M, Dieng Y, Ogutu B, Tiono AB, et al. Efficacy and safety of a combination of azithromycin and chloroquine for the treatment of uncomplicated Plasmodium falciparum malaria in two multi-country randomised clinical trials in African adults. Malar J. 2014;13:458.CrossRefPubMedPubMedCentral
13.
Chandra R, Ansah P, Sagara I, Sie A, Tiono AB, Djimde AA, et al. Comparison of azithromycin plus chloroquine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in children in Africa: a randomized, open-label study. Malar J. 2015;14:108.CrossRefPubMedPubMedCentral
14.
Participants in the 2001 Conference on Ethical Aspects of Research in Developing Countries. Moral standards for research in developing countries: from “reasonable availability” to “fair benefits.” Hast Cent Rep. 2004;34:17–27.
15.
16.
Denburg A, Rodriguez-Galindo C, Joffe S. Clinical trials infrastructure as a quality improvement intervention in low- and middle-income countries. Am J Bioeth. 2016;16:3–11.CrossRefPubMed
17.
Perrey C, Wassenaar D, Gilchrist S, Ivanoff B. Ethical issues in medical research in the developing world: a report on a meeting organised by Fondation Merieux. Dev World Bioeth. 2009;9:88–96.CrossRefPubMed
18.
Lairumbi GM, Parker M, Fitzpatrick R, English MC. Forms of benefit sharing in global health research undertaken in resource poor settings: a qualitative study of stakeholders’ views in Kenya. Philos Ethics Humanit Med. 2012;7:7.CrossRefPubMedPubMedCentral
19.
20.
Douglas-Jones R. A single broken thread: integrity, trust and accountability in Asian ethics review committees. Durham Anthropol J. 2012;18:13–27.
21.
Hedgecoe AM. Trust and regulatory organisations: the role of local knowledge and facework in research ethics review. Soc Stud Sci. 2012;42:662–83.CrossRefPubMed
22.
Hynes T. The issue of “trust” or “mistrust” in research with refugees: choices, caveats and considerations for researchers. Geneva: New Issues in Refugee Research, UNHCR; 2003. p. 1–25.
23.
Pratt B, Lwin KM, Zion D, Nosten F, Loff B, Cheah PY. Exploitation and community engagement: can Community Advisory Boards successfully assume a role minimising exploitation in international research? Dev World Bioeth. 2015;15:18–26.CrossRefPubMed
24.
Manda-Taylor L. Establishing community advisory boards for clinical trial research in Malawi: engendering ethical conduct in research. Malawi Med J. 2013;25:96–100.PubMedPubMedCentral
25.
Lefeber Y, Voorhoever H. Practices and beliefs of traditional birth attendants: lessons for obstetrics in the north? Tropical Med Int Health. 1997;2:1175–9.CrossRef
26.
Grietens KP, Ribera JM, Erhart A, Hoibak S, Ravinetto RM, Gryseels C, et al. Doctors and vampires in sub-Saharan Africa: ethical challenges in clinical trial research. Am J Trop Med Hyg. 2014;91:213–5.CrossRefPubMed
27.
Kingori P, Muchimba M, Sikateyo B, Amadi B, Kelly P. “Rumours” and clinical trials: a retrospective examination of a paediatric malnutrition study in Zambia, southern Africa. BMC Public Health. 2010;10:556.CrossRefPubMedPubMedCentral
28.
Pfizer. Building infrastructure: Good Clinical Practice and Ethical Review Clinical Case Study Series; 2009. p. 1–6.
29.
Hurst SA. Vulnerability in research and health care; describing the elephant in the room? Bioethics. 2008;22:191–202.CrossRefPubMed
30.
Chiumento A, Khan MN, Rahman A, Frith L. Managing ethical challenges to mental health research in post-conflict settings. Dev World Bioeth. 2016;16:15–28.CrossRefPubMed
31.
Fitzgerald DW, Marotte C, Verdier RI, Johnson WD Jr, Pape JW. Comprehension during informed consent in a less-developed country. Lancet. 2002;360:1301–2.CrossRefPubMed
32.
Tekola F, Bull SJ, Farsides B, Newport MJ, Adeyemo A, Rotimi CN, et al. Tailoring consent to context: designing an appropriate consent process for a biomedical study in a low income setting. PLoS Negl Trop Dis. 2009;e482:3.
Metadata
Title
Multiple-level stakeholder engagement in malaria clinical trials: addressing the challenges of conducting clinical research in resource-limited settings
Authors
George Mtove
Joshua Kimani
William Kisinza
Geofrey Makenga
Peter Mangesho
Stephan Duparc
Miriam Nakalembe
Kamija S. Phiri
Russell Orrico
Ricardo Rojo
Pol Vandenbroucke
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Trials / Issue 1/2018
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-018-2563-1

Other articles of this Issue 1/2018

Trials 1/2018 Go to the issue

Research

Facilitators and challenges in recruiting pregnant women to an infant obesity prevention programme delivered via telephone calls or text messages

Study protocol

Cerebral microembolism in the critically ill with acute kidney injury (COMET-AKI trial): study protocol for a randomized controlled clinical trial

Study protocol

Fluoroscopy with MRA fusion image guidance in endovascular iliac artery interventions: study protocol for a randomized controlled trial (3DMR-Iliac-roadmapping study)

Study protocol

Feasibility and acceptability of PrE-operative Physical Activity to improve patient outcomes After major cancer surgery: study protocol for a pilot randomised controlled trial (PEPA Trial)

Study protocol

Pregabalin versus gabapentin in the treatment of sciatica: study protocol for a randomised, double-blind, cross-over trial (PAGPROS)

Research

Exploring factors associated with views on sharing of certain interim trial result measures by the data safety monitoring board (DSMB) with non-DSMB members